EMA Withdrawn: Zerit (stavudine) — Bristol-Myers Squibb Pharma EEIG

View source ↗

Summary

EMA has withdrawn Zerit (stavudine) for HIV infections; decision dated 13 February 2019.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• HIV Infections

Drugs mentioned

• Zerit (stavudine)

Snippet

Status: Withdrawn. Therapeutic area: HIV Infections. MAH: Bristol-Myers Squibb Pharma EEIG. Decision date: 13/02/2019